Effect of Donepezil on the Reorganization of Cognitive Neural Network in Patients With Post-Stroke Cognitive Impairment
NCT00530478 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2007-09-17
Summary
The purpose of this study is to demonstrate the efficacy and safety of donepezil on the recovery of cognitive function in patients with stroke and to delineate the neurophysiologic mechanisms of the therapeutic effect of donepezil on the recovery of cognitive network using functional neuroimaging technique.
Conditions
Interventions
- DRUG
-
Donepezil
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
Suk Hoon Ohn, MD, MS · Samsung Medical Center
-
Yun Hee Park, MD · Samsung Medical Center
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- South Korea
Study Locations
More Related Trials
-
Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
NCT02695004 ·Status: COMPLETED ·Phase: PHASE1
-
Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
NCT04730635 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease
NCT00744978 ·Status: COMPLETED ·Phase: PHASE2
-
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
NCT01129596 ·Status: COMPLETED
-
Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease
NCT02787746 ·Status: COMPLETED ·Phase: PHASE4
-
Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development
NCT01487395 ·Status: COMPLETED ·Phase: PHASE1
-
Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
NCT05565976 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
NCT02648906 ·Status: UNKNOWN ·Phase: PHASE4
-
Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
NCT00501111 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.
NCT02178124 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease
NCT02260674 ·Status: COMPLETED ·Phase: PHASE2
-
Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease
NCT00602680 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients
NCT05050604 ·Status: UNKNOWN ·Phase: PHASE4
-
Zydena on Cognitive Function of Alzheimer's Disease Patients
NCT01940952 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate DNL747 in Subjects With Alzheimer's Disease
NCT03757325 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers
NCT01461174 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil
NCT01712074 ·Status: TERMINATED ·Phase: PHASE2
-
Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine
NCT01380288 ·Status: COMPLETED ·Phase: NA
-
The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients
NCT00480870 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease
NCT01054976 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease
NCT03363269 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients
NCT00202540 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
NCT01266525 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms
NCT02626572 ·Status: COMPLETED ·Phase: PHASE2
-
An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum
NCT02406027 ·Status: TERMINATED ·Phase: PHASE2